The Global Liquid Biopsy Market is segmented on the lines of its type of cancer, product and service, circulation biomarkers, end user and regional. Based on type on cancer it covers lung cancer, colorectal cancer, prostate cancer, breast cancer, liver cancer and other cancers. Product and service is classified into instruments, services and software and reagents. Under circulation biomarkers it covers circulating tumor cells, extracellular vesicles, circulating tumor DNA and other biomarkers. End user segment is classified into academic & research centers, reference laboratories, hospital and physician laboratories and others end user.
Browse Full Report @: https://www.marketresearchengine.com/liquid-biopsy-market
How Big is the Global Liquid Biopsy Market?
The Global Liquid Biopsy Market is expected to exceed more than US$ 2 billion by 2022 and will grow at a CAGR of more than 23% in the given forecast period.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Biocept Inc. (U.S.), Myriad Genetics (U.S.), QIAGEN (Netherlands), Roche (Switzerland), Bio-Rad Laboratories Inc. (U.S.), Trovagene Inc. (U.S.), Guardant Health, Inc. (U.S.), Janssen Diagnostics, LLC (U.S.), Fraunhofer-Gesellschaft (Germany), and MDxHealth SA (U.S.). Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Global Liquid Biopsy Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
Table of Contents
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Industry Insights
7 Liquid Biopsy Market, By Cancer Type
8 Liquid Biopsy Market, By Circulating Biomarker
9 Liquid Biopsy Market, By Products and Services
10 Liquid Biopsy Market, By End User
11 Liquid Biopsy Market, By Region
12 Competitive Landscape
13 Company Profiles
13.2 Biocept, Inc.
13.4 F. Hoffmann-La Roche AG
13.5 Bio-Rad Laboratories Inc.
13.6 Myriad Genetics
13.7 Janssen Diagnostics, LLC.
13.8 Tr0vagene Inc.
13.9 Guardant Health Inc.
13.11 MDX Health SA